AVAYL

Avayl is a biotechnology company leveraging high-throughput functional proteomics and artificial intelligence to accelerate drug discovery. The company's platform integrates advanced mass spectrometry with machine learning to map protein-protein interactions and functional states at an unprecedented scale. By decoding the complexities of the proteome, Avayl aims to identify novel therapeutic targets and develop precision medicines for hard-to-treat diseases. Based in Salt Lake City, the firm was founded by industry veterans with the goal of creating a comprehensive functional map of human biology. Their approach moves beyond static genomic data to capture the dynamic behavior of proteins in living systems.